Inequitable distribution of implantable cardioverter defibrillators in Ontario

International Journal of Technology Assessment in Health Care

Volumn 23, Issue 3, 2007, Pages 354-361

  Udell, Jacob A ^a   Juurlink, David N ^a   Kopp, Alexander ^a   Lee, Douglas S ^a   Tu, Jack V ^a   Mamdani, Muhammad M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute coronary syndromes; Congestive heart failure; Health policy; Implantable cardioverter defibrillator; Primary prevention

Indexed keywords

ACUTE CORONARY SYNDROMES; CONGESTIVE HEART FAILURE; HEALTH POLICY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; PRIMARY PREVENTION;

ECONOMIC AND SOCIAL EFFECTS; IMPLANTS (SURGICAL); PATIENT MONITORING; PREVENTIVE MAINTENANCE;

CARDIOVASCULAR SYSTEM;

ACUTE CORONARY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEFIBRILLATOR; DEMOGRAPHY; FEMALE; HEART ARREST; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; RETROSPECTIVE STUDY; RURAL POPULATION; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME; URBAN POPULATION;

AGE FACTORS; AGED; COHORT STUDIES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEALTH POLICY; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; ONTARIO; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SEX FACTORS; SOCIOECONOMIC FACTORS; UTILIZATION REVIEW;

EID: 34250769381     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307070389     Document Type: Article

References (47)

1. Al-Khatib SM, Anstrom KJ, Eisenstein EL, et al. Clinical and economic implications of the multicenter automatic defibrillator implantation trial-II. Ann Intern Med. 2005;142:593-600.
2. Anand SS, Xie CC, Mehta S, et al. Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Investigators. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol. 2005;46:1845-1851.
3. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002;144:290-296.
4. Ayanian JZ, Epstein AM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-225.
5. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
6. Bearden D, Allman R, McDonald R, et al. Age, race, and gender variation in the utilization of coronary artery bypass surgery and angioplasty in SHEP. SHEP 7. Cooperative Research Group. Systolic hypertension in the elderly program. J Am Geriatr Soc. 1994;42:1143-1149.
7. Bigger JT, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM; the Multicenter Post-Infarction Research Group. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984;69:250-258.
8. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882-1890. [Erratum, N Engl J Med. 2000;342:1300].
9. Cardiac Care Network of Ontario. Advisory panel regarding prophylactic ICDs and resynchronization therapy for management of patients with left ventricular dysfunction and heart failure. Final report and recommendation. February, 2004. Available at: http://www.ccn.on.ca/publications/ Final_ICD_Resynch_Report_2Dec2002_PublicVersion.pdf. Accessed March 13, 2005.
10. Centers for Medicare and Medicaid Services. National coverage analysis: Decision memo for implantable defibrillators (CAG-00157R3). Available at: http://www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id=148. Accessed March 13, 2005.
11. Connolly SJ, Gent M, Roberts RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation. 2000;101:1297-1302.
12. Ezekowitz JA, Armstrong PW, McAllaster FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med. 2003;138:445-452.
13. Fisher JD. Who needs a defibrillator? The beat goes on. J Am Coll Cardiol. 2005;46:1727-1728.
14. Gardner MJ, Leather R, Teo K. Prevention of sudden cardiac death from ventricular arrhythmia: Epidemiology. Can J Cardiol. 2000;26(Suppl C):10C-12C.
15. Ghali WA, Faris PD, Galbraith PD, et al. Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Sex differences in access to coronary revascularization after cardiac catheterization: Importance of detailed clinical data. Ann Intern Med. 2002;136:723-732.
16. Giacomini MK. Gender and ethnic differences in hospital-based procedure utilization in California. Arch Intern Med. 1996;156:1217-1224.
17. Gillis AM. Prophylactic implantable cardioverter-defibrillators after myocardial infarction - not for everyone. N Engl J Med. 2004;351:2540-2542.
18. Glazier RH, Creatore MI, Agha MM, Steele LS. Inner City Toronto Time Trends Working Group. Socio-economic misclassification in Ontario's Health Care Registry. Can J Public Health. 2003;94:140-143.
19. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol. 2002;40:1703-1719.
20. Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003;108:286-291.
21. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: The importance of geography. J Am Coll Cardiol. 2005;45:72-78.
22. Hellermann JP, Jacobsen SJ, Reeder SJ, et al. Heart failure after myocardial infarction: Prevalence of preserved left ventricular systolic function in the community. Am Heart J. 2003;145:742-748.
23. Hohnloser SH, Kuck KH, Dorian P, et al. The DINAMIT Investigators. Prophylactic use of an implantable cardioverterdefibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481-2488.
24. Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:1116-1143.
25. Jauhar S, Slotwiner DJ. The economics of ICDs. N Engl J Med. 2004;351:2542-2544.
26. Josephson ME, Wellens HJ. Implantable defibrillators and sudden cardiac death. Circulation. 2004;109:2685-2691.
27. McAlister FA, Tu JV, Newman A, et al. Howmany patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J. 2005;27:323-329.
28. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 352;3:222-224.
29. Medical Advisory Secretariat, Ontario Ministry of Health and Long-Term Care . Implantable cardioverter defibrillator - prophylactic use. Health technology scientific literature review. June 2003. Available at: http://www.health.gov.on.ca/english/providers/program/mas/reviews/ review_icd_0703.html. Accessed March 13, 2005.
30. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
31. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
32. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation. 1992;85(Suppl):I2- I10.
33. Ng E, Wilkins R, Perras A. How far is it to the nearest hospital? Calculating distances using the Statistics Canada postal code conversion file. Health Rep. 1993;5:179-188.
34. Ovsyshcher IE, Furman S. Determinants of geographic variations in pacemakers and implantable cardioverter defibrillator implantation rates. Pacing Clin Electrophysiol. 2003;26:474-478.
35. Parkes J, Chase DL, Grace A, Cunningham D, Roderick PJ. Inequity of use of implantable cardioverter defibrillators in England: Retrospective analysis. BMJ. 2005;330:454-455.
36. Pauker SG, Estes NAM, Salem DN. Preventing sudden cardiac death: Can we afford the benefit? Ann Intern Med. 2005;142:664-666.
37. Sanders GD, Hlatky MA, Owens DK. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005;353:1471-1480.
38. Sheldon R, O'Brien BJ, Blackhouse G, et al. Canadian Implantable Defibrillator Study (CIDS) Investigators. Effect of clinical risk stratification of cost-effectiveness of the implantable cardioverter-defibrillator: The Canadian Implantable Defibrillator Study. Circulation. 2001;104:1622-1626.
39. Siebels J, Kuck KH. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg) Am Heart J. 1994;127:1139-1144.
40. Solomon SD, Zelenkifske S, McMurray JJV, et al. Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med. 2005;352:2581-2588.
41. The Antiarrhythmic versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
42. The Technology Assessment Unit of the McGill University Health Centre. Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC). A technology assessment. September 2003. Available at: http://upload.mcgill.ca/tau/icd.pdf. Accessed March 13, 2005.
43. Tu JV, Donovan LR, Austin PC, et al. Quality of cardiac care in Ontario. Phase I. Report 2. Toronto: Institute for Clinical Evaluative Sciences; 2005.
44. Tu JV, Donovan LR, Lee DS, et al. Quality of cardiac care in Ontario. Phase I. Report 1. Toronto: Institute for Clinical Evaluative Sciences; 2004.
45. Voigt A, Ezzeddine R, Barrington W, et al. Utilization of implantable cardioverter-defibrillators in survivors of cardiac arrest in the United States from 1996 to 2001. J Am Coll Cardiol. 2004;44:855-858.
46. Wilbur DJ, Zareba W, Hall WJ, et al. Time dependence of mortality and defibrillator benefit after myocardial infarction. Circulation. 2004;109:1082-1084.
47. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation. 1998;98:2334-2351.